Publicaciones en colaboración con investigadores/as de Hospital de Galdakao - Usansolo (28)

2023

  1. Pneumococcal Serotypes Associated with Community-Acquired Pneumonia Hospitalizations in Adults in Spain, 2016–2020: The CAPA Study

    Microorganisms, Vol. 11, Núm. 11

2021

  1. The Evolution and Distribution of Pneumococcal Serotypes in Adults Hospitalized With Community-Acquired Pneumonia in Spain Using a Serotype-Specific Urinary Antigen Detection Test: The CAPA Study, 2011-2018

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Vol. 73, Núm. 6, pp. 1075-1085

2020

  1. Effect of antiviral treatment in older patients hospitalized with confirmed influenza

    Antiviral Research, Vol. 178

2018

  1. A Composite of Functional Status and Pneumonia Severity Index Improves the Prediction of Pneumonia Mortality in Older Patients

    Journal of General Internal Medicine, Vol. 33, Núm. 4, pp. 437-444

  2. Adaptation of antibiotic treatment to clinical practice guidelines in patients aged ≥65 years hospitalised due to community-acquired pneumonia

    Epidemiology and Infection, Vol. 146, Núm. 14, pp. 1870-1877

  3. Asthma and influenza vaccination in elderly hospitalized patients: Matched case-control study in Spain

    Journal of Asthma, Vol. 55, Núm. 4, pp. 391-401

  4. Factors associated with 30-day readmission after hospitalisation for community-acquired pneumonia in older patients: A cross-sectional study in seven Spanish regions

    BMJ Open, Vol. 8, Núm. 3

  5. Repeated influenza vaccination for preventing severe and fatal influenza infection in older adults: A multicentre case-control study

    CMAJ, Vol. 190, Núm. 1, pp. E3-E12

  6. Smoking may increase the risk of influenza hospitalization and reduce influenza vaccine effectiveness in the elderly

    European Journal of Public Health, Vol. 28, Núm. 1, pp. 150-155

2017

  1. Asthma in older people hospitalized with influenza in Spain: A case-control study

    Allergy and Asthma Proceedings, Vol. 38, Núm. 4, pp. 277-285

  2. Costs associated with influenza-related hospitalization in the elderly

    Human Vaccines and Immunotherapeutics, Vol. 13, Núm. 2, pp. 412-416

  3. Effectiveness of 23-valent pneumococcal polysaccharide vaccination in preventing community-acquired pneumonia hospitalization and severe outcomes in the elderly in Spain

    PLoS ONE, Vol. 12, Núm. 2

  4. Factors associated with 30-day mortality in elderly inpatients with community acquired pneumonia during 2 influenza seasons

    Human Vaccines and Immunotherapeutics, Vol. 13, Núm. 2, pp. 450-455

  5. The effectiveness of influenza vaccination in preventing hospitalisations of elderly individuals in two influenza seasons: A multicentre case–control study, Spain, 2013/14 and 2014/15

    Eurosurveillance, Vol. 22, Núm. 34

2016

  1. Effect of influenza vaccination on the prognosis of hospitalized influenza patients

    Expert Review of Vaccines, Vol. 15, Núm. 3, pp. 425-432

  2. Factors associated with influenza vaccination of hospitalized elderly patients in Spain

    PLoS ONE, Vol. 11, Núm. 1

  3. Factors associated with pneumococcal polysaccharide vaccination of the elderly in Spain: A cross-sectional study

    Human Vaccines and Immunotherapeutics, Vol. 12, Núm. 7, pp. 1891-1899

2014

  1. Pneumococcal pneumonia: Differences according to blood culture results

    BMC Pulmonary Medicine, Vol. 14, Núm. 1

2013

  1. Análisis de la discordancia entre la prueba de la tuberculina y el QuantiFERON-TB® Gold In-Tube en estudios de contactos

    Medicina Clinica, Vol. 140, Núm. 7, pp. 289-295

2011

  1. COPD Exacerbation: Mortality Prognosis Factors in a Respiratory Care Unit

    Archivos de Bronconeumologia, Vol. 47, Núm. 2, pp. 79-84